News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nader Francois
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| Nader Francois (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 6,134 options to buy
@ $130.14, valued at
$798.3k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Nader Francois (Director) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Gifted 59,520 shares
@ $0 |
|
| 11/22/2021 |
4
| Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 6,749 shares
@ $0
Disposed/sold 10,000 options to buy
@ $27.97, valued at
$279.7k
Disposed/sold 7,500 options to buy
@ $30.17, valued at
$226.3k
Disposed/sold 10,000 options to buy
@ $34.14, valued at
$341.4k
Disposed/sold 7,500 options to buy
@ $40.61, valued at
$304.6k
Disposed/sold 576 options to buy
@ $41.2, valued at
$23.7k
Disposed/sold 20,000 options to buy
@ $41.48, valued at
$829.6k
Disposed/sold 7,500 options to buy
@ $41.64, valued at
$312.3k
Disposed/sold 8,185 options to buy
@ $52.99, valued at
$433.7k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 07/23/2021 |
4
| Nader Francois (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 13,921 shares
@ $0 |
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,622 shares
@ $0
Granted 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 01/26/2021 |
4
| Nader Francois (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 23,747 shares
@ $0
Disposed/sold 133,447 options to buy
@ $2.81, valued at
$375k
Disposed/sold 32,000 options to buy
@ $10.26, valued at
$328.3k
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2020 |
4
| Nader Francois (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 3,468 shares
@ $0
Granted 941 shares
@ $0 |
|
| 04/30/2020 |
4
| Nader Francois (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 18,270 options to buy
@ $46.37, valued at
$847.2k
|
|
| 01/24/2020 |
4
| Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,377 shares
@ $0
Granted 8,185 options to buy
@ $52.99, valued at
$433.7k
|
|
| 12/11/2019 |
4
| Nader Francois (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 39,720 options to buy
@ $18.87, valued at
$749.5k
Granted 17,889 options to buy
@ $18.87, valued at
$337.6k
|
|
| 06/25/2019 |
4
| Nader Francois (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Converted 23,747 shares
@ $0
Converted 23,747 preferred shares
@ $0 |
|
| 05/17/2019 |
4
| Nader Francois (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 2,726 shares
@ $0 |
|
| 01/29/2019 |
4
| Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,250 shares
@ $0
Granted 7,500 options to buy
@ $41.64, valued at
$312.3k
|
|
| 05/11/2018 |
4
| Nader Francois (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,174 shares
@ $0 |
|
| 03/05/2018 |
4
| Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,250 shares
@ $0
Granted 7,500 options to buy
@ $40.61, valued at
$304.6k
|
|
| 11/30/2017 |
4
| Nader Francois (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 1,977 shares
@ $0 |
|
| 03/14/2017 |
4
| Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,250 shares
@ $0
Granted 7,500 options to buy
@ $30.17, valued at
$226.3k
|
|
| 06/07/2016 |
4
| Nader Francois (Director) has filed a Form 4 on Baxalta Inc|
Txns:
| Disposed/sold 7,657 shares
@ $0
Disposed/sold 5,960 options to buy
@ $30.6, valued at
$182.4k
|
|
| 05/12/2016 |
4
| Nader Francois (Director) has filed a Form 4 on Baxalta Inc|
Txns:
| Granted 4,500 shares
@ $0 |
|
| 03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/30/2013 |
4
| Nader Francois (President, CEO and Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Sold 143,503 shares
@ $33.07, valued at
$4.7M
Sold 6,497 shares
@ $33.6, valued at
$218.3k
Sold 43,458 shares
@ $32.3558, valued at
$1.4M
Exercised 19,350 options
@ $5.05, valued at
$97.7k
Exercised 992 options
@ $5.85, valued at
$5.8k
Exercised 17,008 options
@ $5.85, valued at
$99.5k
Exercised 16,650 options
@ $6.16, valued at
$102.6k
Exercised 9,800 options
@ $5.71, valued at
$56k
|
|
| 02/15/2013 |
4
| Nader Francois (President, CEO and Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 196,018 options to buy
@ $8.23, valued at
$1.6M
Granted 72,904 restricted stock units
@ $0 |
|
| 02/11/2013 |
4
| Nader Francois (President & CEO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 20,299 shares
@ $0
Paid exercise price by delivering 7,193 shares
@ $8.61, valued at
$61.9k
|
|
| 12/26/2012 |
4
| Nader Francois (President & CEO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 11,068 shares
@ $9.1, valued at
$100.7k
|
|
| 02/01/2012 |
4
| Nader Francois (President, CEO and Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 46,313 options to buy
@ $5.71, valued at
$264.4k
|
|
| 02/01/2012 |
4
| Nader Francois (President, CEO and Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 54,000 options
@ $3.34, valued at
$180.4k
|
|
| 11/10/2011 |
4
| Nader Francois (President, CEO and Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Bought 30,000 shares
@ $5.36, valued at
$160.8k
|
|
|
|
|